Food and Drug Administration / FDA) issued a safety alert after receiving reports of multiple patients who suffered adverse events shortly after IV glutathione that was compounded using dietary-supplement grade powder an inappropriate ingredient for sterile injectables
Maintaining the 2C8C range is essential, yet the greatest risk of deviation often occurs during last-mile transit, staging, or final deliverywhen environmental conditions fall outside controlled settings
These molecules help to regulate blood glucose levels, enhance insulin secretion and sensitivity, and reduce appetite
Eli Lilly will assign a brand name before commercial launch, following the pattern used for tirzepatide (Mounjaro for diabetes, Zepbound for obesity)
Changes in texture or consistency also signal damage
What we need now is for some drugs to make it across the finish line. Edited by Nerys Avery/vm/hs/ds More In compliance with the JTI standards More: SWI swissinfo.ch certified by the Journalism Trust Initiative You can find an overview of ongoing debates with our journalists here